一对一还是一对多？丝状病毒疫苗研发的考量因素。
One-for-one or one-for-all? Considerations for filovirus vaccine development.
作者信息
Marzi Andrea
机构信息
Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
出版信息
PLoS Biol. 2025 Apr 14;23(4):e3003142. doi: 10.1371/journal.pbio.3003142. eCollection 2025 Apr.
Abstract
Filoviruses continue to re-emerge in Africa, causing localized public health emergencies. Although vaccination has slowly been implemented for Ebola virus, not for other filoviruses, holistic approaches are needed to broadly protect against filovirus threats.
摘要
丝状病毒继续在非洲再次出现，引发局部公共卫生突发事件。尽管已经开始逐步实施针对埃博拉病毒的疫苗接种，但其他丝状病毒尚未如此，因此需要采取全面的方法来广泛防范丝状病毒的威胁。
Zotero 插件